Accordingly, we found that critical NER-associated genes (ERCC1, ERCC2/XPD, XPA, XPC) were downregulated in HNSCC patients compared with HC, thus explaining in part the reduced NER capacity of these patients. The gene discussed is ERCC1; the disease is head and neck squamous cell carcinoma.